0001140361-15-030472.txt : 20150807
0001140361-15-030472.hdr.sgml : 20150807
20150807162405
ACCESSION NUMBER: 0001140361-15-030472
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150805
FILED AS OF DATE: 20150807
DATE AS OF CHANGE: 20150807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TENET HEALTHCARE CORP
CENTRAL INDEX KEY: 0000070318
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
IRS NUMBER: 952557091
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1445 ROSS AVENUE
STREET 2: SUITE 1400
CITY: DALLAS
STATE: TX
ZIP: 75202
BUSINESS PHONE: 469-893-2200
MAIL ADDRESS:
STREET 1: 1445 ROSS AVENUE
STREET 2: SUITE 1400
CITY: DALLAS
STATE: TX
ZIP: 75202
FORMER COMPANY:
FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROBBINS LAWRENCE M
CENTRAL INDEX KEY: 0001228603
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07293
FILM NUMBER: 151037811
MAIL ADDRESS:
STREET 1: 767 FIFTH AVENUE
STREET 2: 44TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10153
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GLENVIEW CAPITAL MANAGEMENT, LLC
CENTRAL INDEX KEY: 0001138995
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07293
FILM NUMBER: 151037812
BUSINESS ADDRESS:
STREET 1: 767 FIFTH AVENUE
STREET 2: 44TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10153
BUSINESS PHONE: 2128124700
MAIL ADDRESS:
STREET 1: 767 FIFTH AVENUE
STREET 2: 44TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10153
FORMER NAME:
FORMER CONFORMED NAME: GLENVIEW CAPITAL MANAGEMENT LLC
DATE OF NAME CHANGE: 20010420
4
1
doc1.xml
FORM 4
X0306
4
2015-08-05
0
0000070318
TENET HEALTHCARE CORP
THC
0001138995
GLENVIEW CAPITAL MANAGEMENT, LLC
767 FIFTH AVENUE
44TH FLOOR
NEW YORK
NY
10153
0
0
1
0
0001228603
ROBBINS LAWRENCE M
767 FIFTH AVENUE
44TH FLOOR
NEW YORK
NY
10153
0
0
1
0
Common Stock, $0.05 par value
2015-08-05
4
P
0
400217
54.4351
A
15192530
I
See Footnotes 1 and 2
Common Stock, $0.05 par value
2015-08-06
4
P
0
136243
54.0046
A
15328773
I
See Footnotes 1 and 2
Common Stock, $0.05 par value
2015-08-06
4
P
0
161457
54.9052
A
15490230
I
See Footnotes 1 and 2
These shares of the Issuer's Common Stock, $0.05 par value per share (the "Shares") were purchased for the accounts of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P. Glenview Capital Management, LLC serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management, LLC.
Each Reporting Person disclaims beneficial ownership of the Shares except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
This price reflects the weighted average purchase price for open-market purchases of Shares made by the Reporting Persons on August 5, 2015 within a $1.00 range. The actual prices for these transactions range from $54.12 to $55.00, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
This price reflects the weighted average purchase price for open-market purchases of Shares made by the Reporting Persons on August 6, 2015 within a $1.00 range. The actual prices for these transactions range from $53.75 to $54.70, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
This price reflects the weighted average purchase price for open-market purchases of Shares made by the Reporting Persons on August 6, 2015 within a $1.00 range. The actual prices for these transactions range from $54.81 to $55.00, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Exhibit List: The Power of Attorney filed as Exhibit B to the Schedule 13G/A filed by the Reporting Persons on February 14, 2014 is incorporated herein by reference.
/s/ Mark J. Horowitz, President of Glenview Capital Management, LLC and attorney-in-fact for Lawrence M. Robbins
2015-08-07